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Abstract.  The NH2 terminus  of the F,  subunit of the 
paramyxovirus  SV5  fusion protein  (fusion related ex- 
ternal  domain;  FRED) is a hydrophobic domain that is 
implicated  as being involved in mediating  membrane 
fusion.  We have examined the ability of the FRED to 
function as a  combined  signal/anchor  domain by sub- 
stituting  it for the natural  NH2-terminal  signal/anchor 
domain of a model type II integral membrane protein:  the 
influenza virus neuraminidase  (NA) protein.  The hybrid 
protein (NAF) was expressed in eukaryotic cells. The 
FRED was shown to act as a signal sequence, targeting 
NAF to the lumen of the ER, by the fact that NAF ac- 
quired N-linked carbohydrate chains.  Alkali fractionation 
of microsomes indicated that NAF is a soluble protein in 
the lumen of the ER, and the results of NH2-terminal 
sequence analysis showed that the FRED is cleaved at 
a  site predicted to be recognized by signal peptidase. 
NAF was found to be efficiently secreted (t~  ",, 90 
min)  from the cell.  By using a  combination  of sedi- 
mentation  velocity centrifugation  and immunoprecipi- 
tation assays using polyclonal and conformation- 
specific monoclonal  antibodies  it was found that ex- 
tracellular  NAF consisted of a  mixture  of monomers, 
disulfide-linked  dimers,  and tetramers.  The majority of 
the extracellular  NAF molecules were not reactive 
with the conformation-specific  monoclonal  antibodies, 
suggesting they were not folded in a  native form and 
that only the NAF tetramers  had  matured to a  native 
conformation  such that they exhibited NA activity.  The 
available data indicate that NAF is transported  in- 
tracellularly  in multiple  oligomeric and conformational 
forms. 
I 
NTEGRAL membrane proteins have been shown in general 
to contain  two types of hydrophobic domain  that  are 
involved 'in targeting integral membrane proteins to the 
PER membrane,  in initiating their translocation across the 
membrane,  and  in determining  their  topography  in mem- 
branes.  These are the cleavable hydrophobic NH2-terminal 
signal sequences that,  after interaction with the signal rec- 
ognition particle,  initiate the membrane translocation  pro- 
cess and  the  hydrophobic  stop/transfer,  or membrane  an- 
chorage domain, that functions to terminate translocation of 
the protein  by forming  a  stable interaction  with  the lipid 
bilayer (reviewed in  3,  53).  The majority of proteins  that 
span the lipid bilayer once contain an NH2-terminal  signal 
sequence,  an  NH2-terminal  ectodomain,  and a  COOH-ter- 
minal stop/transfer sequence; these proteins have been called 
class I  integral membrane proteins  (14).  However, a  small 
class of proteins (class II) that span the membrane once con- 
rain  an uncleaved hydrophobic segment near the NH2-ter- 
minus that acts as both an internal signal sequence directing 
integration into the membrane and as a domain that anchors 
the polypeptide. These proteins are oriented with an NH2- 
terminal domain in the cytoplasm and a COOH-terminal ec- 
todomain.  Some recent work has indicated that,  except for 
the presence of a cleavage site, the cleaved signal of a class 
I integral membrane protein is structurally and functionally 
equivalent to the noncleaved signal sequences of class II inte- 
gral membrane proteins  (48). 
The fusion protein (F protein)~  of paramyxoviruses is an 
integral membrane protein that promotes the coalescence of 
membranes to cause cell fusion (19, 46).  The F  protein is 
synthesized in a precursor form (F0) which is activated by a 
host cell protease to form the biologically active disulfide- 
linked subunits F, and F2 (46, 47). The NH2 terminus of F~ 
(fusion-related external domain; FRED) is considerably hy- 
drophobic, and this domain is thought to be involved in medi- 
ating fusion. It has recently been shown that the SV5 FRED 
domain can form a stable interaction with membranes. When 
the FRED domain was removed from its normal internal po- 
sition in the SV5 F protein and attached to the COOH termi- 
1. Abbreviations used in this paper: Endo H, endo B-N acetylglucosamini- 
dase H; F protein,  fusion protein; FRED, fusion-related external domain; 
HA,  hemagglutinin;  HA-F,  hemagglutinin-fusion  protein  hybrid;  HN, 
hemagglutinin-neuraminidase;  NA, neuraminidase; NAE neuraminidase- 
fusion protein hybrid. 
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enza virus hemagglutinin [HA]), the hybrid protein (HA-F) 
was converted to one with the properties of an integral mem- 
brane protein (37). It was, thus, of interest to determine if  this 
position effect on the properties of the FRED domain would 
also apply when the FRED domain was placed at the NH2 
terminus of a protein. In yeast, it has been shown that the 
amino acid specificity of signal sequences must be low since 
a great many sequences can replace the signal sequence of 
yeast invertase (20).  Thus, it would not be surprising if the 
SV5 FRED domain could act as a signal sequence. The more 
intriguing question was whether the FRED domain would 
stably anchor a protein in membranes by its NH2 terminus 
(i.e.,  in an "upside-down" orientation as compared with HA- 
F) when it replaced the signal/anchor domain of a class II 
integral membrane protein. A possible complicating factor 
in the experiment is that the FRED domain contains a poten- 
tial site for cleavage by signal peptidase as predicted by yon 
Heijne's rule (52). 
In this paper, we describe the construction and character- 
ization of a hybrid protein (NAF) that contains the cytoplas- 
mic tail and ectodomain of influenza virus neuraminidase 
(NA) with its signal/anchor domain replaced with the SV5 
FRED domain. NA is a well characterized class II integral 
membrane glycoprotein that is a  tetramer consisting of a 
globular box-shaped head (100 x  100  x  60 ~) folded into 
six antiparallel/~ sheets attached to a slender stalk (51). NA 
exists as  a  pair  of disulfide-linked dimers  and disulfide- 
linked tetramers, and these intermolecular bonds occur in 
the stalk region of the molecule (51). We provide data that 
indicate that the hybrid NAF molecule is a soluble protein 
that is secreted from cells. Previously, it has been proposed 
from studies using wild-type integral membrane proteins and 
mutant integral membrane proteins that do not fold correctly, 
including the influenza virus NA (5), that native folding and 
oligomerization is a prerequisite for transport out of the ER 
(16, 23, reviewed in 43). Here, we show that (a) the majority 
of intracellular and extracellular NAF molecules are mono- 
mers and dimers that are not in a native conformation and 
(b) only a small percentage of the secreted molecules form 
a tetramer consisting of  a pair of  disulfide-linked  dimers, and 
only this molecular species is in a native form that is enzy- 
matically active. 
Materials and Methods 
Cells 
Monolayer cultures of  the TC7 clone of CVI cells were grown in DME sup- 
plemented with 10%  FCS as described previously (38). 
Plasmid Construction 
A  full-length eDNA  clone of the  NA  genc of influenza A/Tokyo/3/67 
(H2N2) inserted at the Sal I site of pBR322 that was used previously (26) 
was kindly made available by Dr. Gillian Air (University of  Alabama in Bir- 
mingham, Birmingham, AL).  The NA-specific eDNA was excised from 
pBR322 by digestion with Sal I. The ends of the purified Sal I insert DNA 
were filled-in using 1"4 DNA polymerase, Xho I linkers were added, and 
the DNA was digested first with FnuD H, which cuts the DNA at a unique 
site downstream of the region encoding the NH2-terminal signal/anchor, 
followed by digestion with Xho I to create a Xho I end suitable for ligation 
at the 3' end (mRNA sense) of the NA eDNA. The NA signal/anchor do- 
main was replaced with the F protein FRED domain by using a Xho I-FnuD 
II synthetic DNA fragment. Four oligonucleotides (two sets of complemen- 
tary pairs; see below), encoding the amino acids shown in Fig. 1., were syn- 
thesized by the Northwestern University Biotechnology Facility (Evanston, 
IL) on a DNA synthesizer (model 380B; Applied Biosystems, Inc., Foster 
City, CA) and were purified as described (37). Complementary oligonucleo- 
tides in H20 were incubated at 100°C for 3 rain and annealed by incuba- 
tion at 55°C for 10 rain followed by cooling at room temperature for 10 rain. 
Annealed oligonucleotides were ligated by incubation at 16°C for 16-18 h 
and then digested with FnuD II and Xho I. An ,~,20-foid molar excess of 
annealed and ligated oligonucleotides were ligated to the large NA FnuD 
II-Xho I insert DNA fragment. After heat inactivation of the 1"4 DNA li- 
gase, the ligated NA DNA was digested with Xho I and ligated to DNA from 
the SV-40 late region replacement vector pSVI03 (39), which had been pre- 
viously digested with Xho I and treated with bacterial alkaline phosphatase. 
The resulting plasmid was used to transform Escherichia coli strain DHI, 
and the nncleotide sequence of the first 235 nucleotides of the hybrid gene 
was verified to ensure that the reading frame had been maintained across 
the junction between the synthetic DNA fragment and the NA DNA. The 
oligos used were (a) 5'-TCG AGA ATG AAT CCA AAT CAA AAG TTT 
GCA GGG GTG GTG ATT GGA TTA GCT GCA TrA GGA GTA GCT 
ACT-3'; (b) 5'-GCC GCA CAG GTC ACT GCC GCA GTG GCA CTA GTA 
AAG GCA AAT GAA GGA TCC G-3'; (c) 5'-CTG TGC GGC AGT AGC 
TAC TCC TAA TGC AGC TAA TCC AAT CAC CAC CCC TGC AAA 
CTT TTG ATT TGG ATT CAT TC-3'; and (d) 5'-CGG ATC CTT CAT TrG 
CCT TTA CTA GTG CCA CTG CGG CAG TGA C-3'. 
Transfection, Radioisotopic Labeling of  Polypeptides in 
Infected Cells, lmmunoprecipitation,  and SDS-PAGE 
Transfection of recombinant DNA molecules into CVI cells, preparation of 
virus stocks, and  radioisotopic labeling of infected cell polypeptides at 
40-48 h after infection were carried out as previously described (39), except 
that for metabolic labeling of infected cell proteins monolayers were in- 
cubated in methionine- and cysteine-free DME, and the proteins were la- 
beled  using  Tran[35S]  label  (ICN  Radiochemicals,  Irvine,  CA).  When 
tunicamycin (1 t~g/ml; Calbiochem-Behring Corp., La Jolla, CA) was used, 
it was added to cells 2 h before labeling and maintained during the labeling 
period. Immunoprecipitation was carried out as described previously (11, 
24) using (a) a rabbit polycional serum to Tokyo/67  NA; (b) mAbs NT Tok 
25/4, NT Tok 34/9, or NT Tok 67•7  made to A/Tokyo/67 NA; or (c) mAb 
Jap 11312 made to A/Japan/305/57 NA (25, 27, 54). These antibodies were 
generously made available by Dr. Robert G. Webster (St Jude Children's Re- 
search Hospital, Memphis, TN). Samples were prepared for electrophoresis 
and analyzed by SDS-PAGE on 15 % polyacrylamide gels as described (24). 
Quantitation of autoradiographs using a laser scanning densitometer was 
done as described (18). 
Endo B-N Acetylglucosaminidase H 
(Endo H) Digestions 
Endo H digestion of intracellular NAF protein was carried out as described 
previously (37).  For Endo H digestion of secreted NAF protein, an equal 
volume of2x RIPA buffer (24) was added to the supernat~mt medium from 
infected cells, and the samples were treated as above. 
Microsome Preparation and Protein Fractionation 
Microsomes were prepared according to the method of Adams and Rose (1) 
as described previously (37).  Alkali fractionation of microsomal proteins 
was performed as previously described (37). 
Sedimentation Velocity Centrifugation of NAF 
Protein on Sucrose Gradients 
SV-40-NAF recombinant virus-infected CV1 cells were labeled for either 
15 rain or 1 h (depending on the experiment) with 200 #Ci Tran[35S] label 
in 2 ml methionine- and cysteine-free DME/10-cm dish. After the labeling 
period, the medium was removed and replaced with 1 mi of DME contain- 
ing 2 mM cold methionine and cysteine (chase medium), and incubation 
was continued for varying periods.  The  supernatant  medium was cen- 
trifuged at 10,000 g for 5 rain to remove any cellular debris, and an 0.1 vol 
of 10x lysis buffer (100 mM phosphate buffer, pH 7.2, 1 M NaCI, 10% Tri- 
ton X-100) was added. The lysate (0.5 nil) was layered on top of a 10.5-ml 
5-25% (wt/vol) sucrose gradient in  10 mM phosphate, pH 7.2,  100 mM 
NaCI, 0.1% Triton X-100 over an 0.75-ml  60%  (wt/voi) sucrose cushion. 
The gradients were centrifuged for 16.75 h at 38,000 rpm at 20°C in an SW41 
The Journal  of Cell Biology,  Volume 110, 1990  1000 c 
F2  ~ FRED  F1  A 
FRED 
L  Met:.A_~_":_~._:~.:9~  ".£i~'h"~a"Glr v~'v'I -ne-6trL,,,-Aaa - 
- Ala  -Leu -Gl~,-Val-Ala  -Thr-AlaiAla-GIn  -Val  -Thr-Ala-Ala-Val-Ala.Leu- 
Figure L  Schematic diagram illustrating the NAF hybrid protein. The SV5 F protein and the influenza virus NA are depicted at the top 
in schematic form. The F protein signal sequence (S) is illustrated as the dashed box, and the F protein stop/transfer membrane anchor 
domain (A) is illustrated by the vertically hatched box. The FRED domain is represented by the horizontally hatched box. The arrow marks 
the cleavage/activation (c) site of the F protein. The NA cytoplasmic tail of six amino acid residues is represented by the solid box, and 
the NA signal/anchor (S/A) domain is illustrated by a diagonally hatched box. The NAF recombinant molecule was constructed by annealing 
together four oligonucfeotides and inserting them into a vector that expresses NA but from which the cytoplasmic tail and signal/anchor 
domain of NA had been deleted (see Materials and Methods). In the expanded insert to the NAF schematic diagram, the dashed rectangles 
show the amino acid residues encoded by NA (the six residues of the cytoplasmic tail and the beginning of the NA ectodomain), and the 
solid rectangle shows the 26 amino acids of the SV5 FRED domain followed by four residues of the F~ subunit of the F protein. The Gly- 
Ser dipeptide located between FRED and the ectodomain is encoded by six nueleotides that were inserted into the construction because 
they contain a Barn HI restriction endonuclease site that facilitated identification of the correct recombinant DNA construction. The double 
arrowheads within the FRED domain indicate a site predicted by yon Heijne's rule (52) that was a candidate site to be cleaved by signal 
peptidase. 
rotor (Beckman Instruments, Inc., Fullerton, CA) before fractionation into 
16 × 0.75-ml fractions from the bottom of the tube. For immunoprecipita- 
tion of gradient  fractions,  an equal volume of 2x  RIPA buffer (24) was 
added  to each  fraction,  and  immunoprecipitation  was performed  as de- 
scribed above. 
NA Assays 
NA activity assays were done as described previously (28). Since sucrose 
interferes with the colorimetric  assay, all samples from sucrose gradients 
were dialyzed against 20 mM phosphate buffer, pH 6.0, overnight and con- 
centrated in the dialysis bag against solid polyethylene glycol 8000. NAF 
NA activity was stable in 20 mM phosphate buffer, losing only 20% of its 
activity after  1 mo at 4°C. 
Direct Amino Acid Sequencing of the NH2 Terminus 
of Secreted NAF 
Monolayers of CV1 cells in 6-cm dishes were infected with a P1 stock of 
the  SV-40-NAF  recombinant  virus.  At  40-48  h  after  infection,  cell 
monolayers were labeled with 375/~Ci/ml of [3H]valine (Amersham Corp., 
Arlington Heights, [L) in valine-free DME for 2 h. At the end of the labeling 
period,  the radioactive medium  was removed and replaced with  1 ml of 
DME containing 2 mM valine, and incubation was continued for an addi- 
tional 2 h. The medium was collected and centrifuged at 45,000 rpm at 4°C 
in a TLA 100.2 rotor (Beckman Instruments, Inc.), an equal volume of 2x 
RIPA buffer (24) was added,  and the samples were immunoprecipitated 
using rabbit polyclonal anti-Tokyo/67 NA serum as described above. After 
SDS-PAGE, the proteins were electrobfotted to glass fiber paper, and NH2- 
terminal amino acid sequencing was done as previously described (40, 57) 
using a protein sequencer (Model 477A/120A; Applied Biosystems, Inc.). 
Results 
Rational and Construction of the NAF  Molecule 
We were interested in determining if the SV5 F protein FRED 
domain  could  function  as  an  NH2-terminal  signal/anchor 
domain of a type II integral membrane protein to both direct 
the translocation of a protein across the membrane of the ER 
and then, subsequently, to arrest translocation. The class II 
integral membrane protein reporter molecule that was cho- 
sen to investigate these properties of FRED was the influ- 
enza NA. 
A DNA molecule was constructed, as described in Mate- 
rials and Methods,  such that a hybrid protein consisting of 
the  cytoplasmic tail  and ectodomain of NA with the  SV5 
FRED replacing the natural signal/anchor of NA would be 
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tion,  and differing antibody reactivities. CV1 cells were infected 
with SV-40 recombinant viruses expressing NA or NAE labeled 
with  Tran[35S] label  for 20  min,  and  then  incubated in  chase 
medium for 3 h (A and B). Both the medium (M) and the cells (C) 
were harvested and lysed in RIPA buffer. The labeled proteins were 
immunoprecipitated using the polyclonal Tokyo NA antisera and 
the polypeptides analyzed on SDS-PAGE under reducing (A) or 
nonreducing (B) conditions.  Monomeric  (M),  dimeric  (D),  or 
tetrameric (T) forms of the polypeptides are indicated. (C) CV1 
cells expressing NAF were labeled for 30 min with Tran[3~S] label 
and either harvested immediately for analysis of intracellular NAF 
or incubated in chase medium for 3 h for analysis of secreted NAF. 
Proteins were immunoprecipitated with the rabbit polyclonal Tokyo 
NA antibody (lane POLY)  or mAbs Tok 67/7, Tok 34/9, Jap 113/2, 
or Tok 25/4 (see Materials and Methods) and analyzed on SDS- 
PAGE under nonreducing conditions. 
synthesized. In Fig. 1,~the hybrid protein (NAF) is shown in 
schematic form in comparison with the wild-type NA and F 
proteins. Also shown in Fig.  1 is the sequence of the NH2- 
terminal 47 amino acids of NAE Two residues (Gly and Ser) 
not found in either FRED or the NA ectodomain are present 
at the junction of FRED with NA since they are encoded by 
the nucleotides of a Bam HI site that was inserted to facilitate 
identification of the correct DNA construction. DNA frag- 
ments encoding either the NA or hybrid NAF proteins were 
inserted into the SV-40 late region replacement vector pSV103 
(37),  and  the  nucleotide sequence  across  the  FRED-NA 
junction was verified. 
Expression and Glycosylation of  NAF Protein 
in CV1 Cells 
The SV-40 NA and NAF recombinant DNAs together with 
DNA from an SV-40 early region deletion mutant (42) were 
introduced into CV1 cells by means of DEAE-dextran-medi- 
ated  transfection  (32),  and  virus  stocks  were  prepared. 
Monolayer cultures of CV1 cells were infected with first pas- 
sage stocks of the SV-40 recombinant viruses, and infected 
cell proteins were labeled with Tran[3sS] label at 40-48 h 
after infection. Cell lysates were prepared, immunoprecipi- 
tared with the polyclonal Tokyo NA serum, and analyzed by 
SDS-PAGE  as  described  in  Materials  and  Methods.  As 
shown in Fig.  2 A, a  protein with slightly increased elec- 
trophoretic mobility in comparison with NA was observed 
(Fig. 2 A, lanes NA c and NAF c). 
The addition of N-linked carbohydrate chains to proteins 
occurs in the lumen of the ER. Thus, glycosylation of NAF 
would be indicative of the SV5 FRED acting as a signal and 
directing the translocation of the NA ectodomain into the ER 
lumen, To investigate this possibility, NAF was synthesized 
in the presence of the inhibitor of N-linked glycosylation, 
tunicamycin (1/~g/ml). NAF synthesized in the presence of 
tunicamycin was observed to have a significantly increased 
electrophoretic mobility on SDS-PAGE as compared with 
NAF synthesized in the absence of the drug (data not shown). 
Thus, it was concluded that, as NAF possesses N-linked car- 
bohydrate chains, the NAF ectodomain was translocate~ into 
the lumen of the ER. 
To examine whether the FRED domain, in addition to act- 
ing as a  signal  sequence, had acted as a  stop/transfer se- 
quence,  microsomes  were  isolated  from cells  expressing 
NAF and subjected to alkaline fractionation. At alkaline pH, 
integral membrane proteins remain associated with the lipid 
bilayer and are found in the pellet fraction, and soluble pro- 
teins and proteins peripherally associated with membranes 
are found in the supernatant (2, 17, 37, 49). NAF was found 
almost entirely in the supernatant fraction (data not shown), 
thus indicating that NAF is a  soluble protein that is com- 
pletely translocated into the lumen of the ER. 
Secretion of NAF, lntermolecular Disulfide Bond 
Formation,  and Differing Antibody Reactivities 
Since NAF was found to be a soluble protein in the lumen 
of the ER, it seemed possible that NAF would be secreted. 
CV1  cells expressing NAF  were labeled for 20 rain with 
Tran[35S] label and then incubated in chase medium for 3 h. 
The cell lysate and medium were immunoprecipitated with 
the polyclonal Tokyo NA antibody. As shown in Fig. 2 A, 
NAF was recovered from the medium (lane NAF m) as well 
as from cells (lane NAF c). Expression of NA is shown as 
a  size marker (lane NA c), and no NA was  found in the 
medium (data not shown). Secreted NAF had a slower elec- 
trophoretic mobility on SDS-PAGE than intracellular NAF; 
this  is  thought to  be due to  a  difference in  carbohydrate 
modification of the molecules. The nature of  the minor bands 
seen in Fig. 2 A that coprecipitate with NA and NAF have 
not been investigated at this time. 
To examine for the formation of intermolecular disulfide 
bonds in  NAF,  intracellular and secreted NAF were sub- 
jected to etectrophoresis under nonreducing conditions and 
compared with NA as a control. As shown in Fig. 2 B, NA 
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Figure 3. NH2-terminal  sequence analysis of the NAF 
protein. CV1 cells were infected with the SV-40 recom- 
binant virus expressing NAF and labeled with [3H]- 
valine, and the secreted NAF was immunopreeipitated 
from the medium with polyclonal Tokyo NA antise- 
rum  and  analyzed on  SDS-PAGE.  Labeled protein 
was electroblotted  onto activated glass fiber paper, and 
the region containing the NAF protein excised. Pro- 
tein sequencing was done as described in Materials 
and Methods. The material from each cycle of Edman 
degradation was dried in a scintillation vial and counted 
in a model LS6800 scintillation  counter (Beckman In- 
struments, Inc.). The radioactivity  released from each 
of 20  cycles of Edman  degradation is shown.  The 
peaks of radioactivity  at cycles 3, 7, and 10 correspond 
to valine at NAF residues 25, 29, and 32 (indicated by 
stars), and the arrow indicates that the deduced NH2- 
terminus of secreted NAF protein is the alanine at res- 
idue 23. 
was found as a  mixture of a  pair of disulfide-linked dimers 
and disulfide-linked tetramers that migrated near the top of 
the gel. This confirms work reported previously (51). Intra- 
cellular NAF was predominantly found to migrate on SDS- 
PAGE in  a  position compatible with  it being nondisulfide 
linked (monomer) with a small amount forming a disulfide- 
linked dimer. In contrast, secreted NAF was found to exist 
as an approximately equal mixture of monomers and disul- 
Figure 4. Kinetics of secretion of 
NAE  NAF  recombinant virus- 
infected CVI  cells were labeled 
with Tran[3~S] label for 10 min. 
The cells were then incubated for 
the times indicated in chase medi- 
um, and intraceUular (c; CFJ].) 
and extracellular (m; MEDIUM) 
NAF  was  immunoprecipitated 
with the polyclonal  Tokyo HA an- 
tibody.  (7bp)  Samples  analyzed 
on  SDS-PAGE  under  reducing 
conditions;  (bottom)  Samples 
analyzed  on  SDS-PAGE  under 
nonreducing conditions. 
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tivity in the intracellular NAF species (lane NAF c) and the 
secreted NAF species (lane NAF m) reflects the 20-min la- 
beling and 3-h chase period used since in this time a large 
amount of NAF was secreted (see below). The difference in 
stoichometry between the intraceUular monomers and dim- 
ers and those found extracellularly will be discussed further 
below. 
mAbs that recognize conformational epitopes can be very 
useful reagents to examine the status of folding of a polypep- 
tide (7, 8, 16, 33, 36, 56). To test the ability of  different rnAbs 
to react with the intracellular and extracellular NAF, CVI 
cells expressing NAF were labeled for 30 min with Tran[3sS] 
label, and the cells either harvested immediately or the medi- 
um was replaced with chase medium and the cells were in- 
cubated for 3 h before harvesting the medium. A large panel 
of mAbs to NA, shown previously to bind to different anti- 
genic sites on the mature NA of purified influenza virions, 
were used to immunoprecipitate NAF using conditions of  an- 
tibody excess. The precipitated NAF polypeptides were sub- 
jected to SDS-PAGE under nonreducing conditions. Exam- 
pies illustrating the three different types of reactivity found 
are shown in Fig. 2 C. The rabbit polyclonal Tokyo NA sera 
was used to provide concentration and size marker lanes for 
the NAF monomeric and disulfide-linked species, mAbs Tok 
67/7 and Tok 34/9 immunoprecipitated monomer  s and dimers 
in a  similar ratio from cells,  but these molecular species 
comprised only a subset of the total intracellular NAF mole- 
cules (c.f. lanes POLY, 67~7and 34/9). These two mAbs also 
immunoprecipitated a subset of the extracellular NAF spe- 
cies that is found on gels as monomers and disulfide-linked 
dimers.  In contrast,  mAb Jap  113/2  only immunoprecipi- 
tated a subset of the intracellular and extracellular disulfide- 
linked molecules and none of the monomeric species, mAb 
Tok 25/4 (which was representative of 17 of 20 mAbs tested) 
only immunoprecipitated very small amounts of  intracellular 
NAF but it did precipitate a readily detectable subset of the 
extracellular NAF dimeric species. The population of NAF 
molecules immunoprecipitated by mAb Tok 25/4 had a small 
but reproducible difference in electrophoretic mobility as 
compared with the species precipitated by the Jap 113/2 anti- 
body, which may reflect either differences in intramolecular 
disulfide bond formation or differences in carbohydrate mod- 
ification. In comparison with the data obtained with NAF, 
the three different mAbs could quantitatively immunoprecip- 
itate influenza virus NA in amounts comparable with the 
polyclonal Tokyo NA  sera  (data  not shown).  It has been 
shown previously that the Jap 113/2 and Tok 25/4 mAbs bind 
to different sites on NA (26) and, whereas the Jap 113/2 anti- 
body only slightly inhibits the NA activity of NA, the Tok 
25/4 antibody completely inhibits NA activity (26; Paterson, 
R. G., and R. A.  Lamb, unpublished observations). Thus, 
in aggregate, these data suggest that in the cell and medium 
species of NAF can be found that differ not only by the for- 
mation of intermolecular disulfide bonds but also by differ- 
ing reactivities with specific antibodies, suggesting that in- 
tracellular and extracellular NAF exists in  several folded 
states. In addition, the data indicate that the reactivity of the 
mAbs with the extracellular forms of NAF 3 h after the label- 
ing period (particularly the dimer species) was much greater 
than that observed with the intracellular species after a 30- 
min labeling period, suggesting that the immunological reac- 
tivity of the NAF molecules matures with time. 
NH2-terminal Sequencing of NAF  Indicates Cleavage 
within the FRED Domain 
The finding that the FRED domain acted as a signal sequence 
to direct NAF to the ER membrane but then failed to act as 
a stop/transfer sequence suggested at least two possible ex- 
planations for the results obtained. Although the FRED do- 
main could act as a stop/transfer sequence when it replaced 
such a domain at the COOH terminus of a type I  integral 
membrane protein (37), when the FRED domain is placed 
at the NH2 terminus of a type II integral membrane protein 
as in NAE the hydrophobicity of the FRED domain may not 
be sufficient to halt transport of the growing NAF chain due 
to the driving force of  protein translocation and/or chain syn- 
thesis. Alternatively, NAF could have become a soluble pro- 
tein due to proteolytic cleavage of the FRED domain in the 
ER mediated either by signal peptidase or another ER pro- 
teolytic activity. To distinguish between these possibilities, 
the amino acid sequence of the NH~ terminus of purified 
[3H]valine-labeled NAF was determined. As shown in Fig. 
3,  peaks  of 3H  radioactivity were recovered after FAman 
degradation cycles 3, 7, and 10. The only place in the entire 
NAF sequence where valine is found with this periodicity is 
within the FRED domain, and, therefore, the mature NH2 
terminus of NAF is alanine at NAF residue 23. Thus, a pro- 
teolytic cleavage event had  occurred  in  the  hydrophobic 
FRED domain of NAE 
Rate of  Secretion of  NAF 
To determine the rate of secretion of NAF from cells, recom- 
binant virus-infected cells were labeled with TranpsS] label 
for 10 min and then incubated in chase medium for varying 
periods up to 4 h. Intracdlular and secreted NAF were im- 
munoprecipitated with polyclonal Tokyo NA antibody and 
analyzed  on  SDS-PAGE  under  reducing  conditions.  As 
shown in Fig. 4, top, >90% of NAF is secreted in 4  h of 
chase period,  and  the  rate of NAF  secretion has a  t~  of 
~90 min, a rate that is very similar to that for transport of 
NA to the cell surface (5; Paterson, R. G., and R. A. Lamb, 
unpublished observations).  Since virtually all the synthe- 
sized NAF molecules were secreted in 4 h, it indicates that 
secretion of NAF is efficient. Analysis of samples under non- 
reducing conditions from a similar experiment (Fig. 4, bot- 
tom) showed a more complex series of intraceUular and ex- 
tracellular NAF species. In the cell, immediately after the 
pulse label, the majority of NAF was monomeric. During the 
chase period, NAF exhibited a faster electrophoretic mobil- 
ity that was presumably due to trimming of  mannose residues 
from the core oligosaccharides, a process known to begin in 
the ER and continue in the Golgi apparatus (22). In addition 
to NAF monomers, some disulfide-linked NAF dimers were 
observed 10 min after the labeling period, and, within 20 
min, two slower migrating NAF dimeric species were ob- 
served. These data did not demonstrate straightforward ki- 
netics for the interconversion of the monomer to the dimer 
form of NAF nor did they show the interconversion of the 
faster migrating NAF dimer form to the slower migrating 
forms. However, with time the intracellular NAF monomers 
The Journal of Cell Biology,  Volume  110, 1990  1004 Figure 5. Secreted NAF carbohydrate chains are resistant to digestion with Endo H. NAF recombinant virus-infected CVI cells were labeled 
with Tran[3~S  l label for 15 min and incubated in chase medium for the varying indicated times. Intracellular or secreted NAF molecules 
were immunoprecipitated with polyclonal Tokyo NA antiserum, incubated with (+) or without (-) Endo H as described in Materials and 
Methods, and analyzed on SDS-PAGE under nonreducing conditions. (Left) Intracellular NAF; (right) secreted NAE D and M, disulfide- 
linked dimers and monomers, respectively; Ds and Ms, Endo H-sensitive dimers and monomers, respectively; Dr and Mr, Endo H-resis- 
tant dimers and monomers, respectively. 
and all three dimer species were lost from the cell. In the 
medium, NAF monomer and disulfide-linked dimer species 
could be identified and they accumulated with time. Nearly 
equivalent amounts  of extracellular NAF  monomers  and 
disulfide-linked dimers were found, and they were in a ratio 
different to  that  found for the  intracellular NAF  species. 
Thus, the simplest explanation for these data is that after for- 
marion of the interchain disulfide bond NAF dimers rapidly 
exit from the cell. In addition, these data indicate that forma- 
tion of the disulfide bond is not obligatory for secretion of 
NAF from the cell. The reactivity pattern of the conforma- 
tion-specific mAbs  was  investigated  in  a  pulse  label  and 
chase protocol using the same time points as shown in Fig. 
4. However, very little intracellular NAF was precipitated by 
the mAbs at any time, and reactivity for the mAbs did not 
change with time (data not shown). These data are compati- 
ble with the notion that after acquisition of reactivity for the 
mAbs NAF is rapidly secreted. 
Acquisition of  Endo H-resistant Carbohydrate 
Chains on NAF 
To determine whether NAF acquired resistance to Endo H 
digestion, indicative of the conversion of carbohydrate chains 
from the simple to complex form in the medial-Golgi  com- 
plex,  recombinant virus-infected cells  were labeled  with 
Tran[3sS] label for 15 min and incubated in chase medium 
for varying periods. Intracellular and secreted NAF were im- 
munoprecipitated, incubated with or without Endo H, and 
analyzed on SDS-PAGE under nonreducing conditions (Fig. 
5). The majority of intracellular NAF molecules were found 
to be sensitive to Endo H  digestion, and, as would be ex- 
pected from the data shown in Fig. 4, they were found largely 
to consist of the NAF monomer species. In contrast, almost 
all the detectable extracellular NAF dimers and 65 % of the 
extracellular  NAF  monomers  were  resistant  to  Endo  H 
digestion.  However, 35%  of extracellular NAF monomers 
were Endo H sensitive. The simplest explanation of the ob- 
servation that very small amounts of dimeric Endo H-resis- 
tant product are found in the cell whereas extracellular di- 
meric NAF is largely resistant to Endo H digestion is that, 
after modification of the NAF N-linked carbohydrate chains 
from the simple to complex type, the molecules are rapidly 
secreted.  The finding that  a  proportion of the monomers 
were  sensitive  to  Endo  H  digestion  suggests  that  these 
monomers are passing through the Golgi apparatus in a form 
that is less accessible to the processing enzymes. 
Oligomeric Forms of the ExtraceUular NAF Protein 
To examine the oligomeric form of secreted NAF by a non- 
denaturing assay,  radioactively labeled secreted NAF  was 
fractionated by centrifugation on sucrose density gradients. 
Fractions were collected from the bottom of the gradients 
and immunoprecipitated with the four NA antisera that have 
different specificities, and the polypeptides were analyzed on 
SDS-PAGE under nonreducing conditions.  Fractions were 
also assayed for NA enzyme activity. Three discrete NAF 
species were identified using the rabbit polyclonal Tokyo NA 
antibody (Fig. 6, POLY).  Near the bottom of the gradient, 
in fractions 4 and 5, an NAF species was found that on gels 
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forms of  extracellular NAF on su- 
crose density gradients and their 
differing antibody and enzymatic 
activities.  NAF recombinant vi- 
rus-infected  CV1  ceils  were  la- 
beled with Tran[35S] label for 1 h 
and  incubated  in  chase medium 
for 2  h.  The NAF secreted into 
the medium was fraetionated on 
sucrose gradients as described in 
Materials and Methods. Samples 
collected from the bottom of the 
gradient  were  immunoprecipi- 
tated  with  the  polyelonal Tokyo 
NA antisera or the three confor- 
mation-specific mAbs Tok 67/7, 
Jap 113/2, or Tok 25/4. NA activ- 
ity assays on sucrose density gra- 
dient fractions were performed as 
described in Materials and Meth- 
ods.  (Fraction  1) Bottom of the 
gradient; (fraction 15) top of the 
gradient. Polypeptides were ana- 
lyzed on SDS-PAGE  under non- 
reducing  conditions.  D  and  M 
indicate  the  approximate  elec- 
trophoretic positions of the vari- 
ous disulfide-linked dimeric and 
monomerie species, respectively. 
was  a  dimer,  and  this  NAF  species  cosediments  with  NA 
(data not shown).  Thus, this species of NAF is presumed to 
be a tetramer composed of a pair of disulfide-linked dimers. 
In the middle of the gradient,  in fractions 7--9, an NAF spe- 
cies Was found that on gels was also a disulfide-linked dimer 
and thus by its sedimentation characteristics  is presumed to 
be an  NAF dimer.  Near  the top of the gradient  (fractions 
10-12), an NAF species was found that on gels was a mono- 
mer,  and,  from its  sedimentation  characteristics,  it  seems 
reasonable to assume it is an NAF monomer.  It should  be 
noted that only disulfide-linked dimers or pairs of disulfide- 
linked  dimers  could  be  recovered  from  the  NAF  species 
sedimenting  in the dimeric and tetrameric positions on the 
gradient  and  that  no  nondisulfide-linked  dimeric  or  tetm- 
meric species were observed.  The mAb Tok 67/7 immuno- 
precipitated the same three NAF species (Fig. 6, TOK 67/7) 
as the polyclonal Tokyo NA antibody.  However, the ratio of 
the amount of NAF monomer as compared with oligomeric 
NAF precipitated by this mAb was different from that found 
with  the  polyclonal  antibody.  This  suggests  that  the  NAF 
monomer exists in more than one conformational form which 
can be distinguished by use of the two antisera. The mAb Jap 
113/2 (Fig. 6, JAP 113/2) only recognized the NAF tetramer 
and a proportion of the dimer forms and did not precipitate 
any NAF monomer.  The mAb Tok 25/4 (Fig.  6,  TOK 25/4) 
only precipitated  the NAF  tetrarner  and  not the dimers or 
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cipitations of secreted NAF for 
depletion of specific antibody-re- 
active forms. NAF recombinant 
virus-infected CV1 cells were la- 
beled with Tranl~SS] label for 1 h 
and incubated in chase medium 
for 2 h. The medium was incu- 
bated sequentially  with two rounds 
of an excess of mAbs Tok 25/4 
and Jap 113/2 and the rabbit poly- 
clonal Tokyo NA antibody. Anti- 
body at each stage was removed 
by addition of protein A-agarose 
beads.  Polypeptides were ana- 
lyzed by SDS-PAGE under non- 
reducing  conditions. Only  the 
material  precipitated  from  the 
first rounds of immunoprecipita- 
tion are shown since the second 
rounds contained <5%  of anti- 
body-reactive NAF species. 
monomers.  Thus,  these  data  suggest  that  the  tetramers, 
dimers, and monomers of NAF have some epitopes that are 
shared and some that are oligomer specific and thus presum- 
ably the three forms also have different folded states. A fur- 
ther indication of a molecule approaching its native confor- 
mation is that it has enzymatic activity. Consequently, NAF 
species separated on sucrose gradients were assayed for NA 
activity. As shown in Fig. 6, bottom, the only species of NAF 
associated with NA activity was the tetmmeric form. Ap- 
proximately 90% of the enzymatic activity loaded onto the 
sucrose gradient was recovered in the tetramer-containing 
fractions, indicating that the centrifugation conditions had 
not inactivated biological activity. The mAb Tok 25/4, but 
not mAb Jap 113/2, has been shown previously to inhibit en- 
zymatic activity (26).  Addition of mAb Tok 25/4 to the gra- 
dient fractions before the NA assay completely eliminated all 
enzymatic activity (data not shown), which provides further 
evidence that the tetrameric form of NAF recognized by the 
mAb Tok 25/4 is the biologically active form. Unfortunately, 
because of the low amounts of NAF protein produced by the 
SV-40 recombinant vectors it was not possible to derive an 
enzyme-specific activity for NAF and to compare it with that 
for NA. 
To exclude further the possibility that the NAF dimers and 
monomers only appeared on sucrose gradients due to the dis- 
ruption  of tetramers  under  the  centrifugation conditions, 
sequential  rounds  of depletion  immunoprecipitation were 
performed on secreted NAF using antibodies of  differing re- 
activities. NAF was first precipitated in two sequential im- 
munoprecipitations with mAb Tok 25/4 that is specific for 
the enzymatically active and tetrameric NAF. The superna- 
tant, depleted of NAF molecules reactive with this antibody, 
was then immunoprecipitated in two sequential immunopre- 
cipitations with mAb Jap 113/2. Lastly, the supernatant de- 
pleted of NAF species reactive with the mAbs was immuno- 
precipitated with the polyclonal Tokyo NA antibody. When 
the polypeptides from the sequential reactions were analyzed 
under nonreducing conditions on SDS-PAGE  (Fig. 7),  the 
antibodies were found to precipitate the same species and in 
similar stoichiometry as found in Fig. 2, which strongly sug- 
gests that NAF exists in the medium in different conforma- 
tional and oligomeric forms before being subject to centrifu- 
gation. 
The Oligomeric Forms of  lntraceUular  NAF 
For proteins transported through the exocytotic pathway, in- 
cluding influenza virus NA, it has been found that native 
folding and oligomerization  is a prerequisite for transport out 
of  the ER (5, 16, 23, 43). Although the majority of intracellu- 
lar  and  extracellular NAF  molecules are  monomers and 
dimers that do not react with the Tok 25/4 oligomer-specific 
mAb, the data described above does not provide information 
about the oligomeric form of the molecule during intracellu- 
lar transport. It could be argued that the antigenlcally imma- 
ture extracellular NAF monomers were not secreted in that 
form but instead formed an antigenically mature tetramer of 
nondisulfide-linked  molecules for intracellular transport and 
because of the tetramer's rapid secretion immediately after 
its formation it could not be detected using the Tok 25/4 
oligomer-specific mAb. On secretion, this hypothetical spe- 
cies would have to dissociate and undergo conformational 
changes to yield the antigenlcally immature monomers. If  an 
mAb were available  that only recognized antigenicaily im- 
mature NAF monomers, it would be a very useful reagent 
to study this problem directly, but, unfortunately, one has not 
been identified. To address this question indirectly, NAF was 
pulse labeled for 15 rain, and the intracellular oligomeric 
forms of NAF were examined after varying chase times on 
sucrose gradients. Fractions were immunoprecipitated with 
the polyclonal Tokyo NA  antibody, and the polypeptides 
were analyzed under nonreducing conditions on SDS-PAGE. 
As shown in Fig. 8, NAF existed mostly as a monomer with 
a  small amount of disulfide-linked dimer after the 15 rain 
pulse label. After 30 rain of chase period more disulfide- 
linked dimer had formed, and a very small amount of a NAF 
tetramer species (fractions 5 and 6) consisting of two pairs 
of  disulfide-linked  dimers had formed. After 60 rain of  chase 
period, the relative ratio of NAF monomers, dimers, and 
tetramers had not changed dramatically although the abso- 
lute amount of the species had decreased because NAF is 
secreted by this time (see Fig. 4). In addition, the relative 
amount of  each intracellular species is very similar to the rel- 
ative amounts of the extracellular NAF species.  Thus, no 
evidence for the formation of any intracellular nondisulfide- 
linked dimers or tetramers was obtained. The interpretation 
of all these data that we favor is that some of the NAF mole- 
cules are secreted in a monomeric and immaturely folded 
form. 
Discussion 
The class II integral membrane protein influenza virus NA 
was modified such that its signal/anchor domai  n was replaced 
with the hydrophobic FRED domain of the paramyxovirus 
F protein. The data indicate that the FRED is capable of act- 
ing as a  signal sequence and targets the hybrid molecule, 
NAE to the lumen of the ER. This result was not unantici- 
pated since it has been reported that a great many hydropho- 
bic sequences can replace the signal sequence of yeast in- 
vertase (20).  Previous work has shown that signal/anchor 
Paterson  and Lamb lntracellular Transport and Secretion of NAF  1007 Figure 8.  Kinetic  analysis  of the oligomeric forms of intracellular  NAF on sucrose density gradients.  NAF recombinant virus-infected 
CVI cells were labeled  with Tran[35S] label for 15 min and incubated  in chase medium. At varying times, the intraceUular NAF species 
or,  after 3 h, the secreted  NAF species  (SEC) were fractionated  on sucrose density gradients  as described in Materials  and Methods. 
Fractions were collected from the bottom of the gradients and immunoprecipitated  with polyclonal Tokyo NA serum, and the polypoptides 
were analyzed on SDS-PAGE under nonreducing conditions.  D and M mark the approximate position of  the various disulfide-linked dimeric 
and monomeric species,  respectively. 
domains of class II integral membrane proteins are sufficient 
to target and anchor heterologous proteins in the ER mem- 
brane  (18,  59)  and  that  some  foreign transmembrane  do- 
mains can take the place of a natural signal/anchor domain 
(58). Thus, since the FRED domain has been shown to func- 
tion as a  membrane anchor when transposed to the COOH 
terminus of a soluble molecule (37), it was of interest to de- 
termine whether it had the ability to anchor NAF stably in 
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dicted to be an excellent site for recognition by signal pepti- 
dase  (52)  precluded the determination of whether FRED 
could act as a combined signal/anchor. The FRED domain 
may have failed to act as an anchor because it was not suffici- 
ently hydrophobic and was pulled across the bilayer with 
cleavage occurring  secondarily.  Alternatively, the  FRED 
may not have anchored because the cleavage site was exposed 
to a proteolytic activity (presumably signal peptidase) in the 
lumen of the ER during translocation of the nascent NAF 
chain. A cryptic site for cleavage in a signal/anchor domain 
was identified in invariant chain (I3,) when the cytoplasmic 
tail  was  deleted,  which may have affected its membrane 
anchoring ability (29).  In the natural F protein, where the 
FRED is in an internal position in the molecule, it is trans- 
located across the ER membrane and remains uncleaved. 
However, an explanation for the different cleavage suscepti- 
bilities could be that if the NAF protein FRED is inserted 
into the ER membrane as a loop (3, 48, 55) then it would be 
inverted in the membrane as compared with its orientation 
in the native F protein. It has been proposed for some hydro- 
phobic domains that the difference between their ability to 
act as a signal sequence or a signal/anchor domain is due to 
the presence or absence of a site for cleavage by signal pepti- 
dase (48). We have chosen not to alter the cleavage site within 
FRED  because  then  it  would  no  longer  be  the  natural 
domain. 
The data indicate that NAF is a soluble molecule in the ER 
that is efficiently secreted from the cell (t~a ,,o 90 min), and 
this rate of secretion is very similar to that found for transport 
of NA to the cell surface (5;  Paterson,  R.  G., and R.  A. 
Lamb, unpublished observations). It is widely believed that 
the rate-limiting step in transport in the exocytotic pathway 
is the variable exit times of soluble and membrane-bound 
proteins from the ER, whereas the rate of transport for all 
proteins from the Golgi apparatus to the cell surface is simi- 
lar (12,  31, reviewed in 30, 43).  In the exocytotic pathway, 
protein  disulfide bond  formation is  catalyzed by  protein 
disulfide isomerase, a resident protein of the ER (see 6, 13). 
The observed low but steady-state level of NAF disulfide- 
linked dimers for 60 min after a short pulse label, coupled 
with an  increasing accumulation of dimeric NAF  in the 
medium,  is  compatible with a  rapid  rate of intracellular 
transport after dimer formation. Similarly, the inability to 
detect all but small amounts of intracellular NAF species that 
had acquired resistance to Endo H  digestions whereas the 
majority of extracellular NAF species were resistant to Endo 
H  digestion, supports the idea of rapid transport from the 
medial-Golgi apparatus to the cell surface. 
In other studies on the maturation of integral membrane 
proteins,  mAbs  that recognize protein conformation have 
proven most useful to study the kinetics of folding and oligo- 
merization of integral membrane proteins, especially HA of 
influenza virus, the G glycoprotein of vesicular stomatitis vi- 
rus (VSV G) and the hemagglutinin-neuraminidase (HN) of 
the paramyxovirus SV5 (7, 8, 33, 56). Folding of  the polypep- 
tides towards a native structure is thought in the large part 
to occur in the ER together with the oligomerization process. 
With NAF, very little reactivity of the intracellular mole- 
cules could be obtained with conformation-specific mAbs, 
whereas a  greater reactivity could be gained with the ex- 
tracellular molecules. Again, these findings are compatible 
with a rapid rate of transport after folding of the molecules 
to a form recognizable by the mAbs. More surprising was 
the finding that the majority of extracellular NAF molecules 
had not assumed a form that was recognizable by the mAbs. 
When the oligomeric form of the extracellular NAF spe- 
cies was examined, it was found that there was a mixture of 
different types of species. The majority of molecules were 
in the form of monomers and dimers; however, only a small 
population  of  these  molecules  could  be  recognized  by 
conformation-specific mAbs.  An even smaller amount of 
NAF was found to have matured to a tetrameric form that had 
both enzymatic activity and was recognized by an m.Ab that 
inhibits enzyme activity. Although native folding and oligo- 
merization may be a prerequisite for transport of many pro- 
teins out of the ER (5, 7, 8, 16, 23), the data shown here are 
compatible with the view that incompletely folded and non- 
tetrameric forms of NAF are transported intracellularly and 
are secreted from the cells. However, we cannot completely 
exclude the remote possibility that oligomeric NAF dissoci- 
ates and denatures on release into the medium. We have not 
investigated the possibility that the different NAF forms have 
varying transport  rates,  and,  thus,  the  t~  of 90  min  for 
secretion reported here represents an average for all the NAF 
species. However, virtually all NAF molecules are secreted 
in 4 h, and there was no evidence of extensive turnover of 
species in the ER. Other examples of misfolded or not fully 
folded proteins that are transported to the cell surface include 
a chimeric molecule consisting of the HA ectodomain and 
the VSV G transmembrane domain and cytoplasmic tail (44) 
and the various forms of  a membrane-anchored form of  pyru- 
vate kinase (18). 
Several models for the mechanism by which proteins could 
be  sorted  in the  exocytotic pathway have been  proposed 
(reviewed in 41). For some time it was thought that transport 
of proteins to the cell surface would be mediated through 
receptors that recognize positively acting signals. Latterly, it 
has been suggested, with some evidence provided, that trans- 
port of molecules to the cell surface is by default (bulk flow) 
and that sorting is achieved by selective retention of proteins 
in the ER or Golgi apparatus (35, 41, 45).  Recently, it has 
been shown that the paramyxovirus HN glycoprotein specif- 
ically and transiently interacts with the resident ER protein 
GRP78-BiP.  The duration of this interaction correlates with 
the rate of HN folding and oligomerization (36), suggesting 
that this is a normal role of GRP78-BiP as was previously 
proposed  for  its  interaction  with  immunoglobulin heavy 
chains (4). In addition, many mutant proteins (both soluble 
and membrane bound) that do not fold and oligomerize pro- 
perly, form a  long-lived interaction with GRP78-BiP that 
presumably prevents their further intracellular transport (9, 
16,  21,  34).  We suggest that the NAF molecules that are 
transported  in  an  incompletely folded and  nontetrameric 
form escape retention in the ER because the hypothetical 
retention signals in NAF are buried at an early stage in the 
complex folding process. A possible interaction of  NAF with 
GRP78-BiP remains to be investigated. 
For those integral membrane proteins where it has been 
shown that folding and oligomerization are prerequisites for 
intracellular transport, it has not been possible to uncouple 
all the stages of folding from oligomerization. The formation 
of these oligomers may in part involve their membrane an- 
chorage domains and their degree of fluidity in the lipid 
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ization is dependent on the relative concentration of the in- 
dividual polypeptide chains.  With  NAF,  we do not know 
when the FRED domain is cleaved with respect to comple- 
tion of synthesis of the nascent chain or folding of the mole- 
cule. However, cleavage before the oligomerization process 
begins could well perturb  normal folding and make oligo- 
merization kinetically  unfavorable  since the molecules are 
no longer fixed in two dimensions but are in solution. Thus, 
these data suggest that there may be significant differences 
in the requirement for oligomerization between membrane- 
bound  and  secretory  glycoproteins  for their  intracellular 
transport; it is known that several naturally secreted proteins 
are monomeric (see 9 and references within). In two previ- 
ous reports describing soluble forms of formerly membrane- 
bound proteins,  extracellular monomers have  been  found, 
but the interpretation  of these data is complicated by several 
factors. In studies with soluble forms of influenza virus HA 
(7,  15,  16, 50), differing results have been obtained. In one 
case, secreted HA was shown by cross-linking studies to be 
trimeric (16), whereas, in the other case, HA was found to 
be secreted in a monomeric form (7). These differences could 
be due to the fact that different HA subtypes were used, re- 
flecting subtle differences in the HA molecules, or, alterna- 
tively, because the HA oligomer dissociated on sucrose gra- 
dients. In addition, although a monomeric anchor-minus and 
secreted form of the normally trimeric Rous sarcoma virus 
envelope glycoprotein has been observed on sucrose density 
gradients,  the monomers are thought to have arisen by dis- 
sociation of trimers, probably due to the centrifugation con- 
ditions used (10). Lastly,  it is not known if formation of the 
intermolecular disulfide bond in the stalk region of the NAF 
molecule is a prerequisite or consequence of oligomeriza- 
tion. In the influenza virus NA, the degree of interaction  be- 
tween the four subunits is extensive and involves both hydro- 
phobic and salt-link interactions.  The outside strands of two 
/3 sheets on neighboring subunits  are sufficiently close to- 
gether that their interaction  has been characterized as a con- 
tinuation of the/~ sheet across the interface (51).  Thus, our 
data on NAF emphasizes that oligomerization is a complex 
process that depends on several factors  and once it has oc- 
curred it is unlikely to be easily reversible. 
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